Skip to Content

Logo (Actavis) 153 (Buprenorphine Hydrochloride (Sublingual) 8 mg)

Pill with imprint Logo (Actavis) 153 is Orange, Elliptical / Oval and has been identified as Buprenorphine Hydrochloride (Sublingual) 8 mg. It is supplied by Actavis Pharma, Inc..

Buprenorphine is used in the treatment of chronic pain; opiate dependence - maintenance; opiate dependence - induction; opiate dependence; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Buprenorphine 8 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for Logo (Actavis) 153

Buprenorphine hydrochloride (sublingual) 8 mg Logo (Actavis) 153
Buprenorphine hydrochloride (sublingual) 8 mg Logo (Actavis) 153
Buprenorphine hydrochloride (sublingual) 8 mg Logo (Actavis) 153
Buprenorphine hydrochloride (sublingual) 8 mg Logo (Actavis) 153

Buprenorphine Hydrochloride (Sublingual)

Imprint
Logo (Actavis) 153
Strength
8 mg
Color
Orange
Size
14.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00228-3153
Inactive Ingredients
citric acid anhydrous, FD&C Yellow No. 6, lactose monohydrate, magnesium stearate, mannitol, corn starch, povidone k30, trisodium citrate dihydrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.